.
PhRMA

PhRMA

@PhRMA

Tweets14.2k
Followers71.4k
Following6.8k
Likes1.4k

We represent America's innovative biopharmaceutical research & biotechnology companies. Subscribe to alerts at http://onphr.ma/1MnBqy2 . @SteveUbl CEO

Washington, DC
Joined on February 2010

Statistics

We looked inside some of the tweets by @PhRMA and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
1 day
Average replies
1
Average retweets
5
Average likes
15
Tweets with photos
20 / 100
Tweets with videos
10 / 100
Tweets with links
85 / 100

Last Seen Profiles

@AlikHtx @AlikHtx
@cvantix @cvantix
@coleguini @coleguini
@morikogi1200w @morikogi1200w
@chie81664033 @chie81664033
@BeridzeSergio @BeridzeSergio
@AdamsAunti @AdamsAunti
@sakaki_mi @sakaki_mi
@SideshowLuc @SideshowLuc
@IlNnn @IlNnn
@EEANorwayGrants @EEANorwayGrants
@shian_su @shian_su
@postarzu @postarzu
@Alice_toyonaka @Alice_toyonaka
@SOL_willROCKyou @SOL_willROCKyou
@FullRecruiting @FullRecruiting

There is a whole conversation ongoing about who actually funds and leads in the development of innovative new #medicines. This conversation conflates the roles of public and private sector often so it's worth explaining in more detail.

1
3
8
PhRMA
2 days ago

As #HR3 gets voted on, here’s what you need to know about this bill that puts medical innovation at risk: https://catalyst.phrma.org/what-you-need-to-know-about-h.r.-3 

3
2
4
PhRMA
4 days ago

This week in R&D Focus we explore the unique role of the biopharmaceutical industry in the R&D ecosystem. A sneak peek? One of the 4 ways is through translating basic science into new medicines. What are the other 3? @AndrewPowaleny shares more here: https://catalyst.phrma.org/rd-focus-four-ways-the-biopharmaceutical-leads-in-delivering-new-treatments-and-cures 

0
3
5
PhRMA
5 days ago

Nearly half of lymphoma patients treated with Gilead Sciences' CAR-T cell therapy treatment were alive at least three years after a one-time infusion, according to data presented on Saturday. https://reut.rs/345cMlG 

0
3
12
Stephen J. Ubl
1 week ago

New @CMSGov NHE data show last year:
- Physicians/clinical services spending grew 4.1%
- Hospital spending grew 4.5%
- Retail medicine spending grew just 2.5%
- Prices for retail meds fell 1%

We need to look across the entire health care system to address patient affordability

13
38
167

Headline portrays that Government is responsible for biopharmaceutical innovation, reality is that private sector is responsible for >75% of new medicines discovered/developed. Debunking the Myth of Who Funds Biomedical Innovation @PeterPitts https://morningconsult.com/opinions/debunking-the-myth-of-who-funds-biomedical-innovation/ 

3
8
15
PhRMA
1 week ago

“Prices for prescription drugs edged down by 1% last year” http://bit.ly/33TS6wX  via @AP

3
4
6
PhRMA
1 week ago

“Many people may be surprised to find that prices of prescription drugs bought at a pharmacy actually fell by one percent in 2018” https://nyti.ms/2LqYc1y  via @nytimes

2
4
7
PhRMA
1 week ago

New NHE data from @CMSGov show prices for retail medicines FELL 1% last year ↘️The data also show patients continue to pay more out-of-pocket at the pharmacy counter, even though total spending on hospital care is far higher. More in our latest blog https://onphr.ma/34YRRC7 

1
0
1
PhRMA
1 week ago

New poll finds 76% of voters are concerned Speaker Pelosi’s drug pricing plan would result in fewer new medicines. Read more: https://catalyst.phrma.org/new-poll-voters-prefer-more-patient-focused-plan-over-speaker-pelosis-drug-pricing-plan 

0
2
3
PhRMA
1 week ago
An estimated 15 million Americans by 2060: they’re the reason why we must protect innovation and advocate for the R&D necessary to develop new treatments for Alzheimer’s patients, present and future. http://bit.ly/2OOUuki 

An estimated 15 million Americans by 2060: they’re the reason why we must protect innovation and advocate for the R&D necessary to develop new treatments for Alzheimer’s patients, present and future.  http://bit.ly/2OOUuki 

1
1
8
PhRMA
1 week ago

Opinion: We Need to Look Beyond Drugs in Value Assessment https://morningconsult.com/opinions/we-need-look-beyond-drugs-value-assessment/  via @MorningConsult

0
4
4
PhRMA
1 week ago

Hospitals Aren’t Meeting Their Own Modest Cost-Cutting Goals https://news.bloomberglaw.com/health-law-and-business/hospitals-arent-meeting-their-own-modest-cost-cutting-goals 

0
1
2
PhRMA
1 week ago

FACT: #HR3 would cripple biopharmaceutical innovation https://www.phrma.org/Press-Release/Speaker-Pelosis-Drug-Pricing-Plan-Could-Result-in-56-Fewer-New-Medicines-Over-10-Years 

0
0
3

#Vaccines represent one of the most impactful advances in human health, second only to clean water. A new podcast worth listening to explains their value in more detail. #VaccinesWork https://twitter.com/pfizer/status/1199354813688860672 

0
1
14
PhRMA
1 week ago
Investment in R&D has turned HIV from a death sentence into a chronic medical condition. #WorldAIDSDay is a moment to reflect on the progress made for HIV/AIDS patients, and to look forward to the treatments in development. We must protect that hope: http://bit.ly/2r2OmMp 

Investment in R&D has turned HIV from a death sentence into a chronic medical condition. #WorldAIDSDay is a moment to reflect on the progress made for HIV/AIDS patients, and to look forward to the treatments in development. We must protect that hope: http://bit.ly/2r2OmMp 

1
8
5
PhRMA
2 weeks ago
November is #EpilepsyAwarenessMonth. Epilepsy affects about 65 million people worldwide, which is why researchers like Henrik work to develop targeted treatments that give patients and caregivers hope. Read more about the progress: http://bit.ly/2QQp12N 

November is #EpilepsyAwarenessMonth. Epilepsy affects about 65 million people worldwide, which is why researchers like Henrik work to develop targeted treatments that give patients and caregivers hope. Read more about the progress:  http://bit.ly/2QQp12N 

0
1
1
PhRMA
2 weeks ago
The U.S. has led global medial innovation for decades thanks to a strong patent system and pro-innovation policies. But recent policy proposals threaten to give away America’s medical innovation leadership to elsewhere in the world. Read more: http://bit.ly/35DoHID 

The U.S. has led global medial innovation for decades thanks to a strong patent system and pro-innovation policies. But recent policy proposals threaten to give away America’s medical innovation leadership to elsewhere in the world. Read more: http://bit.ly/35DoHID 

3
3
8
PhRMA
3 weeks ago
NEW: Analysis shows that Speaker Pelosi’s drug pricing plan could result in 56 fewer medicines over 10 years https://catalyst.phrma.org/speaker-pelosis-drug-pricing-plan-could-result-in-56-fewer-new-medicines-over-10-years …

NEW: Analysis shows that Speaker Pelosi’s drug pricing plan could result in 56 fewer medicines over 10 years https://catalyst.phrma.org/speaker-pelosis-drug-pricing-plan-could-result-in-56-fewer-new-medicines-over-10-years 

5
10
10
Stephen J. Ubl
3 weeks ago
This morning, I had the chance to kick off the inaugural @statnews Summit. What a great line up of biopharma researchers, policymakers and patient advocates to discuss advances in science and emerging challenges that we need to address to continue to push forward. #STATSummit

This morning, I had the chance to kick off the inaugural @statnews Summit. What a great line up of biopharma researchers, policymakers and patient advocates to discuss advances in science and emerging challenges that we need to address to continue to push forward. #STATSummit

1
6
27
Next Page